Boceprevir and Telaprevir for the Treatment of Chronic Hepatitis C: Safety Management in Clinical Practice

Liver International - United Kingdom
doi 10.1111/j.1478-3231.2011.02707.x
Full Text
Abstract

Available in full text

Categories
Hepatology
Date
Authors
Publisher

Wiley

Related search

Boceprevir in the Treatment of Chronic Hepatitis C Virus Infection

Virus Adaptation and Treatment
VirologyInfectious DiseasesImmunology
2011English

CPC-107 Pharmacotherapy Follow-Up in Chronic Hepatitis C Patients Treated With Boceprevir or Telaprevir

European Journal of Hospital Pharmacy: Science and Practice
Pharmacy
2013English

GRP-041 Collection and Analysis of Adverse Effects and Co-Medications for Outpatients Receiving Boceprevir- Or Telaprevir-Based Treatment for Chronic Hepatitis C

European Journal of Hospital Pharmacy: Science and Practice
Pharmacy
2013English

Effectiveness and Safety of Narlaprevir in Real Clinical Practice of Chronic Hepatitis C

Jurnal Infektologii
Infectious Diseases
2019English

Telaprevir in a Patient With Chronic Hepatitis C and Cryoglobulinemic Glomerulonephritis

Antiviral Therapy
Infectious DiseasesPharmacology
2013English

KDIGO 2018 Clinical Practice Guideline for the Prevention, Diagnosis, Evaluation, and Treatment of Hepatitis C in Chronic Kidney Disease

Nephrology and Dialysis
Nephrology
2019English

New Agents for the Treatment of Hepatitis C Virus &Ndash; Focus on Telaprevir

Virus Adaptation and Treatment
VirologyInfectious DiseasesImmunology
2012English

Cost-Effectiveness of Telaprevir in Genotype 1 Chronic Hepatitis-C Virus Infection in Venezuela

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2013English

The Effect on Gastric Emptying of Telaprevir-Based Triple Therapy for Chronic Hepatitis C Patients

2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy